Abstract
Antigen receptor–controlled checkpoints in B lymphocyte development are crucial for the prevention of autoimmune diseases such as systemic lupus erythematosus. Checkpoints at the stage of pre–B cell receptor (pre-BCR) and BCR expression can eliminate certain autoreactive BCRs either by deletion of or anergy induction in cells expressing autoreactive BCRs or by receptor editing. For T cells, the picture is more complex because there are regulatory T (Treg) cells that mediate dominant tolerance, which differs from the recessive tolerance mediated by deletion and anergy. Negative selection of thymocytes may be as essential as Treg cell generation in preventing autoimmune diseases such as type 1 diabetes, but supporting evidence is scarce. Here we discuss several scenarios in which failures at developmental checkpoints result in autoimmunity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yamagami, T., ten Boekel, E., Andersson, J., Rolink, A. & Melchers, F. Frequencies of multiple IgL chain gene rearrangements in single normal or kappaL chain-deficient B lineage cells. Immunity 11, 317–327 (1999).
von Boehmer, H. et al. Thymic selection revisited: how essential is it? Immunol. Rev. 191, 62–78 (2003).
ten Boekel, E., Melchers, F. & Rolink, A.G. Changes in the V(H) gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor. Immunity 7, 357–368 (1997).
Tung, J.W. & Herzenberg, L.A. Unraveling B-1 progenitors. Curr. Opin. Immunol. 19, 150–155 (2007).
Wardemann, H., Boehm, T., Dear, N. & Carsetti, R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J. Exp. Med. 195, 771–780 (2002).
Loder, F. et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190, 75–89 (1999).
Havran, W.L. & Allison, J.P. Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors. Nature 335, 443–445 (1988).
von Boehmer, H. & Fehling, H.J. Structure and function of the pre-T cell receptor. Annu. Rev. Immunol. 15, 433–452 (1997).
Ciofani, M. et al. Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J. Immunol. 172, 5230–5239 (2004).
Kreslavsky, T., Garbe, A.I., Krueger, A. & von Boehmer, H. T cell receptor-instructed αβ versus γδ lineage commitment revealed by single-cell analysis. J. Exp. Med. 205, 1173–1186 (2008).
von Boehmer, H. Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development. Adv. Immunol. 84, 201–238 (2004).
von Boehmer, H. Positive and negative selection in Basel. Nat. Immunol. 9, 571–573 (2008).
Wardemann, H. & Nussenzweig, M.C. B-cell self-tolerance in humans. Adv. Immunol. 95, 83–110 (2007).
Nemazee, D. Does immunological tolerance explain the waste in the B-lymphocyte immune system? Experiment and theory. Ann. NY Acad. Sci. 764, 397–401 (1995).
Haspel, M.V. et al. Multiple organ-reactive monoclonal autoantibodies. Nature 304, 73–76 (1983).
Radic, M.Z. et al. Residues that mediate DNA binding of autoimmune antibodies. J. Immunol. 150, 4966–4977 (1993).
Barbas, S.M. et al. Human autoantibody recognition of DNA. Proc. Natl. Acad. Sci. USA 92, 2529–2533 (1995).
Rowley, B., Tang, L., Shinton, S., Hayakawa, K. & Hardy, R.R. Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors. J. Autoimmun. 29, 236–245 (2007).
Melchers, F. The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire. Nat. Rev. Immunol. 5, 578–584 (2005).
Ohnishi, K. & Melchers, F. The nonimmunoglobulin portion of λ5 mediates cell-autonomous pre-B cell receptor signaling. Nat. Immunol. 4, 849–856 (2003).
Bradl, H.W.J., Milius, D., Vettermann, C. & Jack, H.M. Interaction of murine precursors B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell-associated heparan sulfate. J. Immunol. 171, 2338–2348 (2003).
Grawunder, U., Haasner, D., Melchers, F. & Rolink, A. Rearrangement and expression of kappa light chain genes can occur without mu heavy chain expression during differentiation of pre-B cells. Int. Immunol. 5, 1609–1618 (1993).
Rolink, A., Melchers, F. & Andersson, J. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 5, 319–330 (1996).
Grawunder, U., Rolink, A. & Melchers, F. Induction of sterile transcription from the kappa L chain gene locus in V(D)J recombinase-deficient progenitor B cells. Int. Immunol. 7, 1915–1925 (1995).
Rolink, A. et al. B cell development in mice with a defective lambda 5 gene. Eur. J. Immunol. 23, 1284–1288 (1993).
Witsch, E.J., Cao, H., Fukuyama, H. & Weigert, M. Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J. Exp. Med. 203, 1761–1772 (2006).
Köhler, F. et al. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity 29, 912–921 (2008).
Ceredig, R., ten Boekel, E., Rolink, A., Melchers, F. & Andersson, J. Fetal liver organ cultures allow the proliferative expansion of pre-B receptor-expressing pre-B-II cells and the differentiation of immature and mature B cells in vitro. Int. Immunol. 10, 49–59 (1998).
Keenan, R.A. et al. Censoring of autoreactive B cell development by the pre-B cell receptor. Science 321, 696–699 (2008).
Lutz, J., Muller, W. & Jack, H.M. VH replacement rescues progenitor B cells with two nonproductive VDJ alleles. J. Immunol. 177, 7007–7014 (2006).
Koralov, S.B., Novobrantseva, T.I., Konigsmann, J., Ehlich, A. & Rajewsky, K. Antibody repertoires generated by VH replacement and direct VH to JH joining. Immunity 25, 43–53 (2006).
Zhang, Z. et al. Contribution of Vh gene replacement to the primary B cell repertoire. Immunity 19, 21–31 (2003).
Chen, C., Nagy, Z., Prak, E.L. & Weigert, M. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity 3, 747–755 (1995).
Nakajima, P.B., Kiefer, K., Price, A., Bosma, G.C. & Bosma, M.J. Two distinct populations of H chain-edited B cells show differential surrogate L chain dependence. J. Immunol. 182, 3583–3596 (2009).
Li, H., Jiang, Y., Prak, E.L., Radic, M. & Weigert, M. Editors and editing of anti-DNA receptors. Immunity 15, 947–957 (2001).
Gerdes, T. & Wabl, M. Autoreactivity and allelic inclusion in a B cell nuclear transfer mouse. Nat. Immunol. 5, 1282–1287 (2004).
Khan, S.N. et al. Editing and escape from editing in anti-DNA B cells. Proc. Natl. Acad. Sci. USA 105, 3861–3866 (2008).
Doyle, C.M., Han, J., Weigert, M.G. & Prak, E.T. Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion. Proc. Natl. Acad. Sci. USA 103, 11264–11269 (2006).
Meffre, E. et al. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J. Exp. Med. 199, 145–150 (2004).
Rolink, A.G. et al. Mutations affecting either generation or survival of cells influence the pool size of mature B cells. Immunity 10, 619–628 (1999).
Yurasov, S. et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201, 703–711 (2005).
Melchers, F. & Rolink, A.R. B cell tolerance–how to make it and how to break it. Curr. Top. Microbiol. Immunol. 305, 1–23 (2006).
Carroll, M.C. A protective role for innate immunity in systemic lupus erythematosus. Nat. Rev. Immunol. 4, 825–831 (2004).
Mackay, F. et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697–1710 (1999).
Rolink, A.G., Tschopp, J., Schneider, P. & Melchers, F. BAFF is a survival and maturation factor for mouse B cells. Eur. J. Immunol. 32, 2004–2010 (2002).
Deane, J.A. et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27, 801–810 (2007).
Shlomchik, M.J. Sites and stages of autoreactive B cell activation and regulation. Immunity 28, 18–28 (2008).
Liu, Y. et al. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J. Immunol. 179, 1340–1352 (2007).
Kumar, K.R. et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 312, 1665–1669 (2006).
Xie, C. et al. PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr. Int. Immunol. 19, 509–522 (2007).
Yamasaki, S. et al. Mechanistic basis of pre–T cell receptor–mediated autonomous signaling critical for thymocyte development. Nat. Immunol. 7, 67–75 (2006).
Aifantis, I. et al. A critical role for the cytoplasmic tail of pTα in T lymphocyte development. Nat. Immunol. 3, 483–488 (2002).
Borgulya, P., Kishi, H., Uematsu, Y. & von Boehmer, H. Exclusion and inclusion of α and β T cell receptor alleles. Cell 69, 529–537 (1992).
Casanova, J.L., Romero, P., Widmann, C., Kourilsky, P. & Maryanski, J.L. T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J. Exp. Med. 174, 1371–1383 (1991).
Padovan, E. et al. Expression of two T cell receptor α chains: dual receptor T cells. Science 262, 422–424 (1993).
Saito, T., Sussman, J.L., Ashwell, J.D. & Germain, R.N. Marked differences in the efficiency of expression of distinct α β T cell receptor heterodimers. J. Immunol. 143, 3379–3384 (1989).
Heath, W.R. et al. Expression of two T cell receptor α chains on the surface of normal murine T cells. Eur. J. Immunol. 25, 1617–1623 (1995).
Yasutomo, K., Doyle, C., Miele, L., Fuchs, C. & Germain, R.N. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate. Nature 404, 506–510 (2000).
Brugnera, E. et al. Coreceptor reversal in the thymus: signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells. Immunity 13, 59–71 (2000).
Swat, W., Ignatowicz, L., von Boehmer, H. & Kisielow, P. Clonal deletion of immature CD4+8+ thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 351, 150–153 (1991).
Sleckman, B.P., Khor, B., Monroe, R. & Alt, F.W. Assembly of productive T cell receptor δ variable region genes exhibits allelic inclusion. J. Exp. Med. 188, 1465–1471 (1998).
Haks, M.C. et al. Attenuation of γδTCR signaling efficiently diverts thymocytes to the αβ lineage. Immunity 22, 595–606 (2005).
Hayes, S.M., Li, L. & Love, P.E. TCR signal strength influences αβ/γδ lineage fate. Immunity 22, 583–593 (2005).
Kreslavsky, T. et al. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of γδ T cells with restricted TCR diversity. Proc. Natl. Acad. Sci. USA 106, 12453–12458 (2009).
Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297–336 (2007).
Chatenoud, L. NKT cells control autoimmunity. J. Clin. Invest. 110, 747–748 (2002).
Lee, P.P. et al. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110, 793–800 (2002).
Yamagata, T., Mathis, D. & Benoist, C. Self-reactivity in thymic double-positive cells commits cells to a CD8 αα lineage with characteristics of innate immune cells. Nat. Immunol. 5, 597–605 (2004).
Guy-Grand, D. & Vassalli, P. Immunology. Tracing an orphan's genealogy. Science 305, 185–187 (2004).
Jordan, M.S. et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301–306 (2001).
Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756–763 (2002).
Aschenbrenner, K. et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat. Immunol. 8, 351–358 (2007).
Liston, A. et al. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc. Natl. Acad. Sci. USA 105, 11903–11908 (2008).
Bautista, J.L. et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. 10, 610–617 (2009).
Huesmann, M., Scott, B., Kisielow, P. & von Boehmer, H. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 66, 533–540 (1991).
Tai, X., Cowan, M., Feigenbaum, L. & Singer, A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6, 152–162 (2005).
Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401–1408 (2004).
Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219–1227 (2005).
Mathis, D. & Benoist, C. A decade of AIRE. Nat. Rev. Immunol. 7, 645–650 (2007).
Hsieh, C.S. A The role of TCR specificity in naturally arising CD25+ CD4+ regulatory T cell biology. Curr. Top. Microbiol. Immunol. 293, 25–42 (2005).
Wing, K. & Sakaguchi, S. Regulatory T cells exert checks and balances on self-tolerance and autoimmunity. Nat. Immunol. 11, 7–13 (2009).
Kisielow, P., Bluthmann, H., Staerz, U.D., Steinmetz, M. & von Boehmer, H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333, 742–746 (1988).
Kappler, J.W., Roehm, N. & Marrack, P. T cell tolerance by clonal elimination in the thymus. Cell 49, 273–280 (1987).
Ramsdell, F. & Fowlkes, B.J. Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 248, 1342–1348 (1990).
Burnet, F.M. The Clonal Selection Theory (Cambridge Univ. Press, London, 1959).
Lederberg, J. Genes and antibodies: do antigens bear instructions for antibody specificity or do they select cell lines that arise by mutation? Science 129, 1649–1653 (1959).
Ohki, H., Martin, C., Corbel, C., Coltey, M. & Le Douarin, N.M. Tolerance induced by thymic epithelial grafts in birds. Science 237, 1032–1035 (1987).
Salaün, J. et al. Thymic epithelium tolerizes for histocompatibility antigens. Science 247, 1471–1474 (1990).
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151–1164 (1995).
Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330–336 (2003).
Khattri, R., Cox, T., Yasayko, S.A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337–342 (2003).
Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
Brunkow, M.E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68–73 (2001).
Chatila, T.A. et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106, R75–R81 (2000).
Kisielow, P., Teh, H.S., Bluthmann, H. & von Boehmer, H. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 335, 730–733 (1988).
von Boehmer, H., Kirberg, J. & Rocha, B. An unusual lineage of α/β T cells that contains autoreactive cells. J. Exp. Med. 174, 1001–1008 (1991).
Bruno, L., Fehling, H.J. & von Boehmer, H. The α β T cell receptor can replace the γδ receptor in the development of γδ lineage cells. Immunity 5, 343–352 (1996).
Egawa, T., Kreslavsky, T., Littman, D.R. & von Boehmer, H. Lineage diversion of T cell receptor transgenic thymocytes revealed by lineage fate mapping. PLoS One 3, e1512 (2008).
Takahama, Y., Shores, E.W. & Singer, A. Negative selection of precursor thymocytes before their differentiation into CD4+CD8+ cells. Science 258, 653–656 (1992).
Buch, T., Rieux-Laucat, F., Forster, I. & Rajewsky, K. Failure of HY-specific thymocytes to escape negative selection by receptor editing. Immunity 16, 707–718 (2002).
Bouillet, P. et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415, 922–926 (2002).
McCaughtry, T.M., Baldwin, T.A., Wilken, M.S. & Hogquist, K.A. Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla. J. Exp. Med. 205, 2575–2584 (2008).
Baldwin, T.A., Sandau, M.M., Jameson, S.C. & Hogquist, K.A. The timing of TCR α expression critically influences T cell development and selection. J. Exp. Med. 202, 111–121 (2005).
Smith, C.A., Williams, G.T., Kingston, R., Jenkinson, E.J. & Owen, J.J. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337, 181–184 (1989).
Wack, A. et al. Direct visualization of thymocyte apoptosis in neglect, acute and steady-state negative selection. Int. Immunol. 8, 1537–1548 (1996).
von Boehmer, H. Developmental biology of T cells in T cell-receptor transgenic mice. Annu. Rev. Immunol. 8, 531–556 (1990).
Nemazee, D. Receptor editing in lymphocyte development and central tolerance. Nat. Rev. Immunol. 6, 728–740 (2006).
Sprent, J. & Kishimoto, H. The thymus and negative selection. Immunol. Rev. 185, 126–135 (2002).
Swat, W., Dessing, M., von Boehmer, H. & Kisielow, P. CD69 expression during selection and maturation of CD4+8+ thymocytes. Eur. J. Immunol. 23, 739–746 (1993).
Bonasio, R. et al. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol. 7, 1092–1100 (2006).
Anderson, M.S. et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395–1401 (2002).
Wicker, L.S. et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun. 25 (suppl.), 29–33 (2005).
Anderson, M.S. et al. The cellular mechanism of Aire control of T cell tolerance. Immunity 23, 227–239 (2005).
Kishimoto, H. & Sprent, J. A defect in central tolerance in NOD mice. Nat. Immunol. 2, 1025–1031 (2001).
Zucchelli, S. et al. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 22, 385–396 (2005).
Liston, A. et al. Impairment of organ-specific T cell negative selection by diabetes susceptibility genes: genomic analysis by mRNA profiling. Genome Biol. 8, R12 (2007).
Pugliese, A. et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15, 293–297 (1997).
Jaeckel, E., Lipes, M.A. & von Boehmer, H. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat. Immunol. 5, 1028–1035 (2004).
Sakaguchi, N. et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426, 454–460 (2003).
Sarukhan, A., Garcia, C., Lanoue, A. & von Boehmer, H. Allelic inclusion of T cell receptor α genes poses an autoimmune hazard due to low-level expression of autospecific receptors. Immunity 8, 563–570 (1998).
Hahn, M., Nicholson, M.J., Pyrdol, J. & Wucherpfennig, K.W. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat. Immunol. 6, 490–496 (2005).
Garcia, K.C., Teyton, L. & Wilson, I.A. Structural basis of T cell recognition. Annu. Rev. Immunol. 17, 369–397 (1999).
Suri, A., Levisetti, M.G. & Unanue, E.R. Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? Curr. Opin. Immunol. 20, 105–110 (2008).
Acknowledgements
Supported by the Deutsche Forschungsgesellschaft (Koselleck grant P.S.ME 2764/1-1 to F.M.) and the US National Institutes of Health (ROI AI 045846, R37 AI 053102, ROI AI 051378 and POI CA 10990 to H.v.B.).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
F.M. is cofounder and member of the board of directors of 4-Antibody AG, Basel, Switzerland, a biotechnology company that generates and improves human monoclonal antibodies.
Rights and permissions
About this article
Cite this article
von Boehmer, H., Melchers, F. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 11, 14–20 (2010). https://doi.org/10.1038/ni.1794
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.1794
This article is cited by
-
Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases
Nature Aging (2022)
-
Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD
Neurotherapeutics (2022)
-
B Cell Aberrance in Lupus: the Ringleader and the Solution
Clinical Reviews in Allergy & Immunology (2022)
-
The role of B cells in atherosclerosis
Nature Reviews Cardiology (2019)
-
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
Leukemia (2019)